Cryo-Cell International, Inc. (CCEL)
4.75
+0.10
(+2.15%)
USD |
NYAM |
Oct 20, 16:00
4.73
-0.02
(-0.42%)
Pre-Market: 20:00
Cryo-Cell International Research and Development Expense (TTM) : 0.304M for Aug. 31, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| August 31, 2026 | 0.304M |
| May 31, 2026 | 0.312M |
| February 28, 2026 | 0.3439M |
| November 30, 2025 | 0.3763M |
| August 31, 2025 | 0.5961M |
| May 31, 2025 | 0.7284M |
| February 28, 2025 | 0.8378M |
| November 30, 2024 | 1.242M |
| August 31, 2024 | 1.382M |
| May 31, 2024 | 1.532M |
| February 29, 2024 | 1.596M |
| November 30, 2023 | 1.172M |
| August 31, 2023 | 0.804M |
| May 31, 2023 | 0.5402M |
| February 28, 2023 | 0.3164M |
| November 30, 2022 | 0.3848M |
| August 31, 2022 | 0.3388M |
| May 31, 2022 | 0.2686M |
| February 28, 2022 | 0.1909M |
| November 30, 2021 | 0.0499M |
| August 31, 2021 | 0.0265M |
| May 31, 2021 | 0.0177M |
| February 28, 2021 | 0.0243M |
| November 30, 2020 | 0.0239M |
| August 31, 2020 | 0.0337M |
| Date | Value |
|---|---|
| May 31, 2020 | 0.0348M |
| February 29, 2020 | 0.03M |
| November 30, 2019 | 0.0301M |
| August 31, 2019 | 0.0402M |
| May 31, 2019 | 0.06M |
| February 28, 2019 | 0.0843M |
| November 30, 2018 | 0.0918M |
| August 31, 2018 | 0.0824M |
| May 31, 2018 | 0.0604M |
| February 28, 2018 | 0.04M |
| November 30, 2017 | 0.0412M |
| August 31, 2017 | 0.0423M |
| May 31, 2017 | 0.0559M |
| February 28, 2017 | 0.059M |
| November 30, 2016 | 0.0531M |
| August 31, 2016 | 0.0478M |
| May 31, 2016 | 0.0439M |
| February 29, 2016 | 0.0425M |
| November 30, 2015 | 0.0458M |
| August 31, 2015 | 0.0463M |
| May 31, 2015 | 0.0542M |
| February 28, 2015 | 0.062M |
| November 30, 2014 | 0.0644M |
| August 31, 2014 | 0.0606M |
| May 31, 2014 | 0.0509M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Dogecoin Cash, Inc. | -- |
| Privia Health Group, Inc. | -- |
| Strata Critical Medical, Inc. | 4.275M |
| DocGo, Inc. | 14.12M |
| Syra Health Corp. | 0.0552M |